Crossmark

DDX21 functions as a potential novel oncopromoter in pancreatic ductal adenocarcinoma: a comprehensive analysis of the DExD box family

Published Online: 2024-08-03

Authors

Wu, Shaohan

Sun, Xiaofang

Hua, Ruheng

Hu, Chundong

Qin, Lei https://orcid.org/0009-0003-4903-0702
Funding

Funding for this research was provided by:

Science and Technology Program of Jiaxing (2023AD31036)

Postgraduate Research & Practice Innovation Program of Jiangsu Province (SJCX23_1669)
License Information

Text and Data Mining valid from 2024-08-03

Version of Record valid from 2024-08-03
More Information

Article History

Received: 10 June 2024

Accepted: 29 July 2024

First Online: 3 August 2024

Declarations

:

: The study protocol was approved by the Ethical Committee of the Second Affiliated Hospital of Jiaxing University (Approval No. 2023-ZFYJ-049-01). This study conformed to the guidelines set by the Declaration of Helsinki. All participants provided written informed consent. All participants also provided informed consent for publication.

: The authors declare no competing interests.

Document is current